Allergic diseases continue to pose a significant public health burden in modernized societies. Although the etiology of allergic diseases is unknown, they are thought to develop as a result of aberrant Th2 immune responses in genetically susceptible individuals. Despite this recognition, the factors driving Th2-mediated immune responses have remained elusive. Our preliminary data suggests the novel paradigm that allergen exposure induces epithelial cell injury which results in the release of an epithelial-derived factor, trefoil factor 2. Tff2, in turn induces the release of the """"""""alarmin"""""""" IL-33, which drives Th2 cytokine production in innate immune cells. The production of Th2 cytokines, amplifies and perpetuates the response by driving additional Tff2 release. Importantly, we show that TFF2 levels are elevated in epithelial cells from asthmatic children undergoing an acute attack as compared to cells from healthy controls. Thus the goal of this proposal is to test the novel hypothesis that aberrant epithelial cell production of TFF2 is important in the induction and expression of Th2-mediated allergic responses in an IL-33-dependent manner. Moreover, we propose that genetic variation in the genes controlling this pathway (TFF2, IL-33, IL-1RL1) enhances the risk of developing allergic diseases (allergic asthma, atopic dermatitis, allergic rhinitis, eosinophilic esphagitis) in children. To test this hypothesis, we propose the following specific aims: 1) To determine the contribution of the Tff2/IL-33 pathway to the initiation of Th2-mediated allergic airway responses;2) To determine the mechanism by which TFF2 mediates IL-13-dependent AHR and mucus cell metaplasia;and 3) To determine whether dysregulation of the TFF2/IL-33 pathway contributes to the risk of developing allergic disorders in cohorts of children recruited from the Cincinnati Area. The studies in this Project are closely aligned with and benefit from the resources and information generated in Projects 1 and 2 of this U19, which are also focused on defining the contribution of altered mucosal epithelial function in the etiology of allergic diseases. Identification of the Tff2/IL-33 pathway as an important driver and amplifier of the allergic response should lead to the development of disease modifying therapies for the treatment of allergic disorders.

Public Health Relevance

Although allergic diseases have long posed a significant public health burden, the factors predisposing some individuals to the development of these disorders are unknown. Herein, we will test the novel hypothesis that dysregulation of the production of an epithelial-derived factor. Trefoil factor 2, drives susceptibility to allergic disorders through a pathway involving the

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI070235-07
Application #
8378566
Study Section
Special Emphasis Panel (ZAI1-PA-I)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
7
Fiscal Year
2012
Total Cost
$495,387
Indirect Cost
$189,453
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Litosh, Vladislav A; Rochman, Mark; Rymer, Jeffrey K et al. (2017) Calpain-14 and its association with eosinophilic esophagitis. J Allergy Clin Immunol 139:1762-1771.e7
Kottyan, L C; Rothenberg, M E (2017) Genetics of eosinophilic esophagitis. Mucosal Immunol 10:580-588
Shik, Dana; Tomar, Sunil; Lee, Jee-Boong et al. (2017) IL-9-producing cells in the development of IgE-mediated food allergy. Semin Immunopathol 39:69-77
Rochman, Mark; Travers, Jared; Miracle, Cora E et al. (2017) Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis. J Allergy Clin Immunol 140:738-749.e3
O'Shea, Kelly M; Aceves, Seema S; Dellon, Evan S et al. (2017) Pathophysiology of Eosinophilic Esophagitis. Gastroenterology :
Wen, Ting; Kuhl, Jonathan; Putnam, Philip et al. (2017) A flow cytometry-based diagnosis of eosinophilic esophagitis. J Allergy Clin Immunol 140:1736-1739.e3
Travers, J; Rochman, M; Caldwell, J M et al. (2017) IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis. Sci Rep 7:17563
Johansson, Elisabet; Biagini Myers, Jocelyn M; Martin, Lisa J et al. (2017) KIF3A genetic variation is associated with pediatric asthma in the presence of eczema independent of allergic rhinitis. J Allergy Clin Immunol 140:595-598.e5
Caldwell, Julie M; Paul, Misu; Rothenberg, Marc E (2017) Novel immunologic mechanisms in eosinophilic esophagitis. Curr Opin Immunol 48:114-121
Caldwell, J M; Collins, M H; Kemme, K A et al. (2017) Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammation. Mucosal Immunol 10:1190-1201

Showing the most recent 10 out of 88 publications